All‐cause mortality ‐ short‐term · health problem or population
It is very uncertain whether summary of findings table ‐ Psychological treatment changes all‐cause mortality ‐ short‐term compared with control (very low certainty).
1 finding from 1 review
All‐cause mortality ‐ short‐term · Anyone diagnosed with AMI
Cells showed no clear difference in all‐cause mortality ‐ short‐term compared with no cells (moderate certainty).
1 finding from 1 review
Short‐term and medium‐term mortality · people with intermediate‐stage hepatocellular carcinoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Short‐term mortality (up to 30 days) · Neonates, children and adults undergoing cardiovascular surgery
1 finding from 1 review
Cardiovascular mortality · Anyone diagnosed with AMI
Cells showed no clear difference in cardiovascular mortality ‐ short‐term compared with no cells (moderate certainty).
1 finding from 1 review
All‐cause short‐term mortality: 1 month · adults with low cardiac output syndrome
It is very uncertain whether enoximone changes all‐cause short‐term mortality: 1 month compared with dobutamine (very low certainty).
1 finding from 1 review
All‐cause short‐term mortality: 1 month · adults with cardiogenic shock or low cardiac output syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause short‐term mortality: 30 days · adults with cardiogenic shock
It is very uncertain whether levosimendan changes all‐cause short‐term mortality: 30 days compared with enoximone (very low certainty).
1 finding from 1 review
All‐cause short‐term mortality: 28 days · adults with cardiogenic shock
It is very uncertain whether epinephrine changes all‐cause short‐term mortality: 28 days compared with norepinephrine‐dobutamine (very low certainty).
1 finding from 1 review
Short‐term mortality (STM)Alive or dead · adults with acute respiratory failure
Mortality: prone position showed no clear difference in short‐term mortality (STM)Alive or dead compared with supine (low certainty).
1 finding from 1 review
All‐cause short‐term mortality: 28 days · adults with cardiogenic shock
It is very uncertain whether epinephrine changes all‐cause short‐term mortality: 28 days compared with norepinephrine (very low certainty).
1 finding from 1 review
Short‐term mortality (30‐day or in‐hospital) · people undergoing elective bifurcated abdominal endovascular aneurysm repair
Totally percutaneous showed no clear difference in short‐term mortality (30‐day or in‐hospital) compared with cut‐down femoral artery access (low certainty).
1 finding from 1 review
Short‐term mortality (30‐day or in‐hospital) · people diagnosed with RAAA
Emergency endovascular aneurysm repair showed no clear difference in short‐term mortality (30‐day or in‐hospital) compared with conventional open repair (moderate certainty).
1 finding from 1 review
All‐cause short‐term mortality: time in hospital · adults with low cardiac output syndrome
It is very uncertain whether dopexamine changes all‐cause short‐term mortality: time in hospital compared with dopamine (very low certainty).
1 finding from 1 review
All‐cause short‐term mortality: range 15 to 31 days · people with cardiogenic shock or low cardiac output syndrome
Levosimendan showed no clear difference in all‐cause short‐term mortality: range 15 to 31 days compared with dobutamine (low certainty).
1 finding from 1 review
Short‐term mortality (in hospital or within 3 months) · patients with oesophageal cancer
It is very uncertain whether laparoscopic changes short‐term mortality (in hospital or within 3 months) compared with open transhiatal oesophagectomy (very low certainty).
1 finding from 1 review
All‐cause short‐term mortality: at intensive care unit · adults with cardiogenic shock
It is very uncertain whether dopamine‐milrinone changes all‐cause short‐term mortality: at intensive care unit compared with dopamine‐dobutamine (very low certainty).
1 finding from 1 review
Short‐term mortality (within hospital stay or closest to one month) · critically ill patients or receiving major surgery
Glutamine‐supplemented nutrition showed no clear difference in short‐term mortality (within hospital stay or closest to one month) compared with non‐supplemented nutrition (low certainty).
1 finding from 1 review
Short‐term mortality All‐cause mortality either in‐hospital or within 3 months · patients with oesophageal cancer
It is very uncertain whether non‐surgical changes short‐term mortality All‐cause mortality either in‐hospital or… compared with surgical treatment of oesophageal cancer (primary outcomes) (very low certainty).
1 finding from 1 review
Short‐term all‐cause mortality (within the first 30 days after the intervention) · people with STEMI and MVD.
It is very uncertain whether complete revascularisation changes short‐term all‐cause mortality (within the first 30 days after the… compared with culprit‐only revascularisation (very low certainty).
1 finding from 1 review